Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: London
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Dechra Pharmaceuticals PLC

+ Add to Watchlist

DPH:LN

934.000 GBp 9.000 0.97%

As of 03:15:45 ET on 03/04/2015.

Snapshot for Dechra Pharmaceuticals PLC (DPH)

Open: 939.500 Day's Range: 933.000 - 939.500 Volume: 3,467
Previous Close: 925.000 52wk Range: 655.000 - 948.500 1-Yr Rtn: +35.56%

Stock Chart for DPH

No chart data available.
  • DPH:LN 934.000
  • 1D
  • 1M
  • 1Y
925.000
Interactive DPH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DPH

Current P/E Ratio (ttm) 36.6772
Estimated P/E(06/2015) 23.7179
Relative P/E vs. UKX 1.6292
Earnings Per Share (GBP) (ttm) 0.2522
Est. EPS (GBP) (06/2015) 0.3900
Est. PEG Ratio -
Market Cap (M GBP) 813.55
Shares Outstanding (M) 87.95
30 Day Average Volume 138,202
Price/Book (mrq) 4.0722
Price/Sale (ttm) 4.1495
Dividend Indicated Gross Yield 1.89%
Cash Dividend (GBp) 5.1200
Dividend Ex-Date 03/12/2015
5 Year Dividend Growth 12.57%
Next Earnings Announcement 09/01/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DPH

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for DPH

Dechra Pharmaceuticals PLC is an international pharmaceutical business focused on the veterinary market, with its key area of specialisation being the development and marketing of companion animal products. The Company Operates under four segments: European Pharmaceuticals, US Pharmaceuticals, Product Development and Services.

Ian David PageCEO/Executive DirectorAnne-Francoise NesmesCFO/Executive Director
Mike EldredPresident:US OperationsTony GriffinMng Dir:Veterinary Products/Exec Dir
More Company Profile & Key Executives for DPH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil